{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:51:40Z","timestamp":1771462300321,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T00:00:00Z","timestamp":1133827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T00:00:00Z","timestamp":1133827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1111\/j.1365-2133.2005.07049.x","type":"journal-article","created":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T13:16:29Z","timestamp":1133874989000},"page":"533-538","source":"Crossref","is-referenced-by-count":51,"title":["Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study"],"prefix":"10.1093","volume":"154","author":[{"given":"E.","family":"Nettis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.","family":"Colanardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Barra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ferrannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tursi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,12,6]]},"reference":[{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1398-9995.1995.tb04258.x","article-title":"A low distribution volume as a determinant of efficacy and safety for histamine (H1) antagonist","volume":"50","author":"Tillement","year":"1995","journal-title":"Allergy"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1034\/j.1398-9995.2001.00726.x","article-title":"A randomized double-blind crossover comparison among cetirizine, levocetirizine and UCB 28557 on histamine-induced cutaneous responses in healthy adult volunteers","volume":"56","author":"Devalia","year":"2001","journal-title":"Allergy"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)61995-3","article-title":"A double-blind, randomized, single dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects","volume":"88","author":"Grant","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1365-2125.2003.01897.x","article-title":"Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin","volume":"56","author":"Purohit","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2125.2002.01611.x","article-title":"Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers","volume":"54","author":"Gandon","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1067\/mai.2000.104939","article-title":"Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression-inhibitory effects of anti-inflammatory drugs","volume":"105","author":"Wedi","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1517\/13543784.11.2.259","article-title":"Antihistamines in late-phase clinical development for allergic disease","volume":"11","author":"Salmun","year":"2002","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1034\/j.1398-9995.2001.00204.x","article-title":"Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin","volume":"56","author":"Clough","year":"2001","journal-title":"Allergy"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1365-2133.2001.04175.x","article-title":"Management and diagnostic guidelines for urticaria and angio-oedema","volume":"144","author":"Grattan","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJM199506293322608","article-title":"Chronic urticaria","volume":"332","author":"Greaves","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.0307-6938.2001.00962.x","article-title":"Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria","volume":"27","author":"Nettis","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0190-9622(99)70495-0","article-title":"Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-Fc\u03b5RI or anti-IgE autoantibodies","volume":"40","author":"Sabroe","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1001\/jama.1992.03490200110012","article-title":"Allergic skin disorders and mastocytosis","volume":"268","author":"Horan","year":"1992","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archderm.1997.03890440085013","article-title":"The pathogenesis of chronic idiopathic urticaria","volume":"133","author":"Sabroe","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/bmj.316.7138.1147","article-title":"ABC of allergies: allergy and the skin. I-urticaria","volume":"316","author":"Greaves","year":"1998","journal-title":"Br Med J"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2133.1997.d01-1168.x","article-title":"The impact of chronic urticaria on the quality of life","volume":"136","author":"O'Donnell","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mai.2000.105706","article-title":"Chronic urticaria","volume":"105","author":"Greaves","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0190-9622(08)80468-9","article-title":"Mast cells and their role in urticaria","volume":"25","author":"Schwartz","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-121-9-199411010-00010","article-title":"The role of leukotrienes in inflammation","volume":"121","author":"Henderson","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199009063231006","article-title":"Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases","volume":"323","author":"Lewis","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1365-2222.2004.02019.x","article-title":"Desloratadine in combination with montelukast in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study","volume":"34","author":"Nettis","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1067\/mai.2003.1559","article-title":"Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria","volume":"112","author":"Nettis","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB24|cit24","first-page":"128","article-title":"Leukotrienes and cytokines in steroid dependent urticaria","volume":"101","author":"Norris","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaci.2003.10.002","article-title":"The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test","volume":"113","author":"Bagenstose","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2005.07049.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0190-9622(95)90233-3","article-title":"Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled comparative trial","volume":"33","author":"Breneman","year":"1995","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2005.07049.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2005.07049.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2005.07049.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:15:36Z","timestamp":1676366136000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/154\/3\/533\/6636644"}},"subtitle":["Levocetirizine in chronic idiopathic urticaria"],"short-title":[],"issued":{"date-parts":[[2005,12,6]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2005.07049.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12,6]]}}}